Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis.

Constantine, Gregory M; Bressler, Peter B; Petroni, Daniel; Metcalfe, Dean D; Carter, Melody C

Constantine, Gregory M; Bressler, Peter B; Petroni, Daniel; Metcalfe, Dean D; Carter, Melody C.

Afiliación

Constantine GM; The National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Allergic Disease, Bethesda, Md. Electronic address: constantinegm@nih.gov.
Bressler PB; Professional Association, Duke University, Durham, NC.
Petroni D; Northwest Allergy and Asthma Center, University of Washington Children's Hospital and Regional Medical Center, Seattle, Wash.
Metcalfe DD; The National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Allergic Disease, Bethesda, Md.
Carter MC; The National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Allergic Disease, Bethesda, Md.

J Allergy Clin Immunol Pract ; 7(4): 1314-1316, 2019 04.

Article en En | MEDLINE | ID: mdl-30149096

Asunto(s)

Anafilaxia/tratamiento farmacológico; Antialérgicos/uso terapéutico; Mastocitosis Sistémica/tratamiento farmacológico; Omalizumab/uso terapéutico; Adulto; Niño; Preescolar; Estudios de Seguimiento; Humanos; Lactante; Masculino; Persona de Mediana Edad; Síncope; Triptasas/sangre; Urticaria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antialérgicos / Mastocitosis Sistémica / Omalizumab / Anafilaxia Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Child / Child, preschool / Humans / Infant / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Pract Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google